"Specializing in the diagnosis and treatment of infectious diseases such as pneumonia, meningitis, HIV, malaria, COVID-19 and more."

During the past decade, Regional Center for Infectious Disease, Wendover Medical Center CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regional Center for Infectious Disease, Wendover Medical Center CRS" #1 collaborator was "Glaxo Wellcome" with 4 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Jacobus Pharmaceutical" with 1 trials as a collaborator and "Washington University School of Medicine" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Regional Center for Infectious Disease, Wendover Medical Center CRS" are "HIV Infections" (16 trials), "Pneumonia, Pneumocystis Carinii" (3 trials), "Mycobacterium Avium-intracellulare Infection" (2 trials) and "Meningitis, Cryptococcal" (1 trials). Many other conditions were trialed in "Regional Center for Infectious Disease, Wendover Medical Center CRS" in a lesser frequency.

Most popular intervention types in "Regional Center for Infectious Disease, Wendover Medical Center CRS" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (7 trials), "Didanosine" (5 trials), "Lamivudine" (5 trials), "Stavudine" (4 trials) and "Lamivudine/Zidovudine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Regional Center for Infectious Disease, Wendover Medical Center CRS" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Regional Center for Infectious Disease, Wendover Medical Center CRS". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Regional Center for Infectious Disease, Wendover Medical Center CRS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regional Center for Infectious Disease, Wendover Medical Center CRS, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".